Across TCGA patient cohorts, LINC02449 mutation is significantly associated with the RNA expression of many other genes, with 50 significant associations in total. STAD shows the largest number of these associations.

The most reproducible LINC02449-associated genes across cancer lineages are LINC02462, PRAMEF32P, and TSPY18P. Each is linked with LINC02449 in more than 1 cancer types. Because this analysis shows association rather than direction, both LINC02449-to-partner and partner-to-LINC02449 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LINC02449→partner) and Y-score (partner→LINC02449) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUAD	LINC02462 →	+0.323	+5.554	<.001	.004	3	2
HNSC	PRAMEF32P →	+0.034	+7.954	<.001	.008	3	1
HNSC	TSPY18P →	+0.069	+7.954	<.001	.008	3	1
HNSC	MIR4693 →	+0.388	+7.954	<.001	.008	3	1
HNSC	MIR6795 →	+0.418	+7.954	<.001	.008	3	1
STAD	RNA5SP326 →	+0.609	+5.026	<.001	.009	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 50 associations by consensus.

Exploration

LINC02449 survival (RNA) · tumor vs normal (RNA) · all LINC02449 data types